CMED's leadership just wants survival, not higher profits.I dumped all my shares for a small profit, especially by comparing to all my other holdings in the sector, my gains on CMED have been below average.
I can't for the life of my figure the thought process of the upper management here, they were in the game 14 YEARS AGO, 1 4, FOURTEEN, and still are not even top 10.
Just look at this week, while every damn weed stock goes on a tear (WEED, APH, ACB, ABCN, MJN, FIRE etc, even ISOL, BLO, N, HEMP and all have had crazy runs to the moon, while CMED stays as is.
The only reason CMED is even at $20 is not of CMED, rather becuase of the ACB and WEED catalysts at play.
I understand the capsules and a stronger R&D, but look at CMED's financials, they by far have the slowest quarter-over-quarter/year-over-year sales growth rate, the current leadership have no hunger for profitability. They want to survive, not profit the shareholders.
The CMED-HIP deal is cool and all, but every annoucement has Tragically Hip's name thrown out as if they are some marketing genius like Kanye, Snoop or even AC/DC.
They are a great band, but it does not signify any creativity or genuis that CMED's execs have done here.
All CMED's CEO had to do was to pick up the damn phone, debate/negotiate with Cam, and the value could have been very easily in CMED's favour.
But nope, they became sitting duck while ACB soared to newer heights with the rest of the sector, and now all CMED gets is either the 20 day volume average or HIP, a below average company with a talented but retired band with no chance of coming back.
Rant over, CMED has a future, but there are much better gains with the competition than CMED, I am happy to be diversified in this sector.